Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GO365 is a comprehensive joint care product line developed by Charak, formulated to support joint and cartilage health, reduce inflammation, and alleviate joint and muscle pain. The product range includes GO365 Nutra Tablets, GO365 Ointment, GO365 Spray, and the GO365 Joint Care Kit. GO365 Nutra Tablets are oral nutraceutical supplements containing a synergistic blend of glucosamine hydrochloride, chondroitin sulfate, calcium carbonate, vitamins (C, D3, E), and Ayurvedic herbs like turmeric (Curcuma longa) and Boswellia serrata, which work internally to prevent cartilage degradation and promote joint lubrication. GO365 Ointment and Spray are topical Ayurvedic formulations containing active herbal ingredients such as capsicum oil, camphor, menthol, wintergreen oil, and eucalyptus oil, which act as counter-irritants and anti-inflammatory agents to provide rapid relief from joint stiffness, sprains, and muscular pain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on GO365.